Treatment of hydronephrosis after Williams tumor

Treatment of hydronephrosis after Williams tumor

Horseshoe kidney, also known as renal fusion or super kidney, is a congenital disorder affecting about 1 in 500 people.[1] In this disorder, the patient’s kidneys fuse together to form a horseshoe-shape during development in the womb.

This condition occurs once in every 500 births and most people are not aware of the situation. In rare cases it can create a Williams tumor – this is what happened to Sasha, a 10 yr old from Russia. The child underwent surgery in Russia but unfortunately the surgeons could not manage the side effects of the operation and the child developed hydronephrosis.

His family approached iMER and Dr. A. Benstein forwarded the medical material for consultation with Dr. Landau who reviewed the situation and decided that the best option would be to repair the kidney at the “Hadassah” Medical Center in Jerusalem.

The child underwent a cystoscopy and during this procedure plastic surgery of the kidney was performed. A short time after his operation, he went home. He returned to Israel for a follow-up visit where the stent was removed. His grandmother’s comments appear below:

“We had great luck that we brought Sasha to your country and to this medical facility. I was most anxious about the trip since I had never been abroad. I didn’t know the language or the place. From our very first moments in Israel we met only positive and kind people.

I extend my vast thanks to the iMER team for your warm reception and smiles and especially for the support that my grandson and myself received during the most difficult times. I send special thanks to Luba, Jennya, Sasha and Yevgeny. To all of the doctors and nurses that helped Sasha and a huge thank you to Dr. Yehezkel Landau who gave us hope that Sasha will live a normal life. The sun will shine on you all forever.” I wish you all happiness and that good luck will be with you forever”.

For more information click here >>

Patients’ Stories

The following letter was written by the J. family to the iMER company. They contacted us while looking for a solution to the medical challenges faced by their 15 year old daughter who was suffering from J.I.A. – Juvenile Idiopathic Arthritis. JIA is a subset of arthritis seen in childhood, which may be transient and self-limited or chronic. It is an autoimmune disorder. Treatment was administered in Russia with Sulfasalazin together with Dicofenac followed by Meloxicam – this protocol brought with it terrible complications. The